4//SEC Filing
MEYER ALAN R 4
Accession 0001140361-20-026650
CIK 0001228627other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 7:42 PM ET
Size
8.7 KB
Accession
0001140361-20-026650
Insider Transaction Report
Form 4
MEYER ALAN R
Director
Transactions
- Purchase
Common Stock
2020-11-19+1,771→ 487,029 total - Purchase
Series A Warrant (right to buy)
2020-11-19+2,679→ 2,679 totalExercise: $4.48From: 2020-11-19Exp: 2025-11-19→ Common Stock (2,679 underlying) - Purchase
Series B Warrant (right to buy)
2020-11-19+315→ 315 totalExercise: $0.00From: 2020-11-19Exp: 2022-01-28→ Common Stock (315 underlying)
Footnotes (2)
- [F1]The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $10,000.
- [F2]Subject to adjustment based on certain price reset provisions.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001212162
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 7:42 PM ET
- Size
- 8.7 KB